Seminoma secondary prevention
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sogand Goudarzi, MD [2]
Overview
Overview
Effective measures for the secondary prevention of seminoma include regular follow-ups for every 2–6 months for the first 3 years and every 6–12 months after 3 years. Tests are often part of follow-up care include blood tests to check serum tumor marker levels, chest x-rays, and CT scans of the abdomen and pelvis.
Secondary Prevention
Secondary Prevention
- Effective measures for the secondary prevention of seminoma include:[1][2]
- Follow-up patients:
- Every 2–6 months for the first 3 years
- Every 6–12 months after 3 years
- Follow-up test include:
- Blood tests to check serum tumor marker levels to see if they returned to normal after treatment
- Chest x-rays to check if cancer has metastasized to the lungs
- CT scans of the abdomen and pelvis to look for any residual disease or that has metastasized elsewhere
- Follow-up patients:
References
References
- ↑ Boujelbene N, Cosinschi A, Boujelbene N, Khanfir K, Bhagwati S, Herrmann E, Mirimanoff RO, Ozsahin M, Zouhair A (August 2011). “Pure seminoma: a review and update”. Radiat Oncol. 6: 90. doi:10.1186/1748-717X-6-90. PMC 3163197. PMID 21819630.
- ↑ Paly, Jonathan J.; Efstathiou, Jason A.; Hedgire, Sandeep S.; Chung, Peter W.M.; O’Malley, Martin; Shah, Anand; Bekelman, Justin E.; Harisinghani, Mukesh; Shipley, William U.; Zietman, Anthony L.; Beard, Clair (2013). “Mapping patterns of nodal metastases in seminoma: Rethinking radiotherapy fields”. Radiotherapy and Oncology. 106 (1): 64–68. doi:10.1016/j.radonc.2012.12.002. ISSN 0167-8140.
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH